APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

IL-17 Targeting Biological Drugs

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global IL-17 Targeting Biological Drugs Market Analysis and Forecast 2026-2032

Report ID 174001620229 December 2025190 pages

Choose your research edition.

Industry ResearchIL-17 Targeting Biological Drugs Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal IL-17 Targeting Biological Drugs Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal IL-17 Targeting Biological Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal IL-17 Targeting Biological Drugs Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal IL-17 Targeting Biological Drugs Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global IL-17 Targeting Biological Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for IL-17 Targeting Biological Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for IL-17 Targeting Biological Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for IL-17 Targeting Biological Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for IL-17 Targeting Biological Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of IL-17 Targeting Biological Drugs include AstraZeneca, DICE Therapeutics, Eli Lilly and Co., Novartis, UCB, Jiangsu Hengrui Medicine, Akesobio and Chongqing Genrix Biopharmaceutical, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for IL-17 Targeting Biological Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of IL-17 Targeting Biological Drugs, also provides the sales of main regions and countries. Of the upcoming market potential for IL-17 Targeting Biological Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the IL-17 Targeting Biological Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global IL-17 Targeting Biological Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for IL-17 Targeting Biological Drugs sales, projected growth trends, production technology, application and end-user industry.

IL-17 Targeting Biological Drugs Segment by Company

AstraZeneca

DICE Therapeutics

Eli Lilly and Co.

Novartis

UCB

Jiangsu Hengrui Medicine

Akesobio

Chongqing Genrix Biopharmaceutical

IL-17 Targeting Biological Drugs Segment by Type

Oral

Injection

IL-17 Targeting Biological Drugs Segment by Application

Hospital

Clinic

Other

IL-17 Targeting Biological Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global IL-17 Targeting Biological Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of IL-17 Targeting Biological Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of IL-17 Targeting Biological Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of IL-17 Targeting Biological Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of IL-17 Targeting Biological Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, IL-17 Targeting Biological Drugs sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global IL-17 Targeting Biological Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Oral Major Manufacturers Table 3. Injection Major Manufacturers Table 4. Global IL-17 Targeting Biological Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Manufacturers Table 6. Clinic Major Manufacturers Table 7. Other Major Manufacturers Table 8. IL-17 Targeting Biological Drugs Industry Trends Table 9. IL-17 Targeting Biological Drugs Industry Drivers Table 10. IL-17 Targeting Biological Drugs Industry Opportunities and Challenges Table 11. IL-17 Targeting Biological Drugs Industry Restraints Table 12. Global IL-17 Targeting Biological Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global IL-17 Targeting Biological Drugs Revenue by Region (2021-2026) & (US$ Million) Table 14. Global IL-17 Targeting Biological Drugs Revenue by Region (2027-2032) & (US$ Million) Table 15. Global IL-17 Targeting Biological Drugs Revenue Market Share by Region (2021-2026) Table 16. Global IL-17 Targeting Biological Drugs Revenue Market Share by Region (2027-2032) Table 17. Global IL-17 Targeting Biological Drugs Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 18. Global IL-17 Targeting Biological Drugs Sales by Region (2021-2026) & (K Units) Table 19. Global IL-17 Targeting Biological Drugs Sales by Region (2027-2032) & (K Units) Table 20. Global IL-17 Targeting Biological Drugs Sales Market Share by Region (2021-2026) Table 21. Global IL-17 Targeting Biological Drugs Sales Market Share by Region (2027-2032) Table 22. Global IL-17 Targeting Biological Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global IL-17 Targeting Biological Drugs Revenue Market Share by Manufacturers (2021-2026) Table 24. Global IL-17 Targeting Biological Drugs Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global IL-17 Targeting Biological Drugs Sales Market Share by Manufacturers (2021-2026) Table 26. Global IL-17 Targeting Biological Drugs Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global IL-17 Targeting Biological Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global IL-17 Targeting Biological Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global IL-17 Targeting Biological Drugs Manufacturers, Product Type & Application Table 30. Global IL-17 Targeting Biological Drugs Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global IL-17 Targeting Biological Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global IL-17 Targeting Biological Drugs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global IL-17 Targeting Biological Drugs Revenue by Type (2021-2026) & (US$ Million) Table 35. Global IL-17 Targeting Biological Drugs Revenue by Type (2027-2032) & (US$ Million) Table 36. Global IL-17 Targeting Biological Drugs Revenue Market Share by Type (2021-2026) Table 37. Global IL-17 Targeting Biological Drugs Revenue Market Share by Type (2027-2032) Table 38. Global IL-17 Targeting Biological Drugs Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 39. Global IL-17 Targeting Biological Drugs Sales by Type (2021-2026) & (K Units) Table 40. Global IL-17 Targeting Biological Drugs Sales by Type (2027-2032) & (K Units) Table 41. Global IL-17 Targeting Biological Drugs Sales Market Share by Type (2021-2026) Table 42. Global IL-17 Targeting Biological Drugs Sales Market Share by Type (2027-2032) Table 43. Global IL-17 Targeting Biological Drugs Price by Type (2021-2026) & (US$/Unit) Table 44. Global IL-17 Targeting Biological Drugs Price by Type (2027-2032) & (US$/Unit) Table 45. Global IL-17 Targeting Biological Drugs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global IL-17 Targeting Biological Drugs Revenue by Application (2021-2026) & (US$ Million) Table 47. Global IL-17 Targeting Biological Drugs Revenue by Application (2027-2032) & (US$ Million) Table 48. Global IL-17 Targeting Biological Drugs Revenue Market Share by Application (2021-2026) Table 49. Global IL-17 Targeting Biological Drugs Revenue Market Share by Application (2027-2032) Table 50. Global IL-17 Targeting Biological Drugs Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 51. Global IL-17 Targeting Biological Drugs Sales by Application (2021-2026) & (K Units) Table 52. Global IL-17 Targeting Biological Drugs Sales by Application (2027-2032) & (K Units) Table 53. Global IL-17 Targeting Biological Drugs Sales Market Share by Application (2021-2026) Table 54. Global IL-17 Targeting Biological Drugs Sales Market Share by Application (2027-2032) Table 55. Global IL-17 Targeting Biological Drugs Price by Application (2021-2026) & (US$/Unit) Table 56. Global IL-17 Targeting Biological Drugs Price by Application (2027-2032) & (US$/Unit) Table 57. AstraZeneca Company Information Table 58. AstraZeneca Business Overview Table 59. AstraZeneca IL-17 Targeting Biological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. AstraZeneca IL-17 Targeting Biological Drugs Product Portfolio Table 61. AstraZeneca Recent Development Table 62. DICE Therapeutics Company Information Table 63. DICE Therapeutics Business Overview Table 64. DICE Therapeutics IL-17 Targeting Biological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. DICE Therapeutics IL-17 Targeting Biological Drugs Product Portfolio Table 66. DICE Therapeutics Recent Development Table 67. Eli Lilly and Co. Company Information Table 68. Eli Lilly and Co. Business Overview Table 69. Eli Lilly and Co. IL-17 Targeting Biological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Eli Lilly and Co. IL-17 Targeting Biological Drugs Product Portfolio Table 71. Eli Lilly and Co. Recent Development Table 72. Novartis Company Information Table 73. Novartis Business Overview Table 74. Novartis IL-17 Targeting Biological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Novartis IL-17 Targeting Biological Drugs Product Portfolio Table 76. Novartis Recent Development Table 77. UCB Company Information Table 78. UCB Business Overview Table 79. UCB IL-17 Targeting Biological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. UCB IL-17 Targeting Biological Drugs Product Portfolio Table 81. UCB Recent Development Table 82. Jiangsu Hengrui Medicine Company Information Table 83. Jiangsu Hengrui Medicine Business Overview Table 84. Jiangsu Hengrui Medicine IL-17 Targeting Biological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Jiangsu Hengrui Medicine IL-17 Targeting Biological Drugs Product Portfolio Table 86. Jiangsu Hengrui Medicine Recent Development Table 87. Akesobio Company Information Table 88. Akesobio Business Overview Table 89. Akesobio IL-17 Targeting Biological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Akesobio IL-17 Targeting Biological Drugs Product Portfolio Table 91. Akesobio Recent Development Table 92. Chongqing Genrix Biopharmaceutical Company Information Table 93. Chongqing Genrix Biopharmaceutical Business Overview Table 94. Chongqing Genrix Biopharmaceutical IL-17 Targeting Biological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Chongqing Genrix Biopharmaceutical IL-17 Targeting Biological Drugs Product Portfolio Table 96. Chongqing Genrix Biopharmaceutical Recent Development Table 97. North America IL-17 Targeting Biological Drugs Revenue by Type (2021-2026) & (US$ Million) Table 98. North America IL-17 Targeting Biological Drugs Revenue by Type (2027-2032) & (US$ Million) Table 99. North America IL-17 Targeting Biological Drugs Sales by Type (2021-2026) & (K Units) Table 100. North America IL-17 Targeting Biological Drugs Sales by Type (2027-2032) & (K Units) Table 101. North America IL-17 Targeting Biological Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 102. North America IL-17 Targeting Biological Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 103. North America IL-17 Targeting Biological Drugs Revenue by Application (2021-2026) & (US$ Million) Table 104. North America IL-17 Targeting Biological Drugs Revenue by Application (2027-2032) & (US$ Million) Table 105. North America IL-17 Targeting Biological Drugs Sales by Application (2021-2026) & (K Units) Table 106. North America IL-17 Targeting Biological Drugs Sales by Application (2027-2032) & (K Units) Table 107. North America IL-17 Targeting Biological Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 108. North America IL-17 Targeting Biological Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 109. North America IL-17 Targeting Biological Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 110. North America IL-17 Targeting Biological Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 111. North America IL-17 Targeting Biological Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 112. North America IL-17 Targeting Biological Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 113. North America IL-17 Targeting Biological Drugs Sales by Country (2021-2026) & (K Units) Table 114. North America IL-17 Targeting Biological Drugs Sales by Country (2027-2032) & (K Units) Table 115. North America IL-17 Targeting Biological Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 116. North America IL-17 Targeting Biological Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 117. United States IL-17 Targeting Biological Drugs Revenue (2021-2032) & (US$ Million) Table 118. Canada IL-17 Targeting Biological Drugs Revenue (2021-2032) & (US$ Million) Table 119. Mexico IL-17 Targeting Biological Drugs Revenue (2021-2032) & (US$ Million) Table 120. Europe IL-17 Targeting Biological Drugs Revenue by Type (2021-2026) & (US$ Million) Table 121. Europe IL-17 Targeting Biological Drugs Revenue by Type (2027-2032) & (US$ Million) Table 122. Europe IL-17 Targeting Biological Drugs Sales by Type (2021-2026) & (K Units) Table 123. Europe IL-17 Targeting Biological Drugs Sales by Type (2027-2032) & (K Units) Table 124. Europe IL-17 Targeting Biological Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 125. Europe IL-17 Targeting Biological Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 126. Europe IL-17 Targeting Biological Drugs Revenue by Application (2021-2026) & (US$ Million) Table 127. Europe IL-17 Targeting Biological Drugs Revenue by Application (2027-2032) & (US$ Million) Table 128. Europe IL-17 Targeting Biological Drugs Sales by Application (2021-2026) & (K Units) Table 129. Europe IL-17 Targeting Biological Drugs Sales by Application (2027-2032) & (K Units) Table 130. Europe IL-17 Targeting Biological Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 131. Europe IL-17 Targeting Biological Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 132. Europe IL-17 Targeting Biological Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 133. Europe IL-17 Targeting Biological Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 134. Europe IL-17 Targeting Biological Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 135. Europe IL-17 Targeting Biological Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 136. Europe IL-17 Targeting Biological Drugs Sales by Country (2021-2026) & (K Units) Table 137. Europe IL-17 Targeting Biological Drugs Sales by Country (2027-2032) & (K Units) Table 138. Europe IL-17 Targeting Biological Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 139. Europe IL-17 Targeting Biological Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 140. Germany IL-17 Targeting Biological Drugs Revenue (2021-2032) & (US$ Million) Table 141. France IL-17 Targeting Biological Drugs Revenue (2021-2032) & (US$ Million) Table 142. U.K. IL-17 Targeting Biological Drugs Revenue (2021-2032) & (US$ Million) Table 143. Italy IL-17 Targeting Biological Drugs Revenue (2021-2032) & (US$ Million) Table 144. Russia IL-17 Targeting Biological Drugs Revenue (2021-2032) & (US$ Million) Table 145. Spain IL-17 Targeting Biological Drugs Revenue (2021-2032) & (US$ Million) Table 146. Netherlands IL-17 Targeting Biological Drugs Revenue (2021-2032) & (US$ Million) Table 147. Switzerland IL-17 Targeting Biological Drugs Revenue (2021-2032) & (US$ Million) Table 148. Sweden IL-17 Targeting Biological Drugs Revenue (2021-2032) & (US$ Million) Table 149. Poland IL-17 Targeting Biological Drugs Revenue (2021-2032) & (US$ Million) Table 150. China IL-17 Targeting Biological Drugs Revenue by Type (2021-2026) & (US$ Million) Table 151. China IL-17 Targeting Biological Drugs Revenue by Type (2027-2032) & (US$ Million) Table 152. China IL-17 Targeting Biological Drugs Sales by Type (2021-2026) & (K Units) Table 153. China IL-17 Targeting Biological Drugs Sales by Type (2027-2032) & (K Units) Table 154. China IL-17 Targeting Biological Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 155. China IL-17 Targeting Biological Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 156. China IL-17 Targeting Biological Drugs Revenue by Application (2021-2026) & (US$ Million) Table 157. China IL-17 Targeting Biological Drugs Revenue by Application (2027-2032) & (US$ Million) Table 158. China IL-17 Targeting Biological Drugs Sales by Application (2021-2026) & (K Units) Table 159. China IL-17 Targeting Biological Drugs Sales by Application (2027-2032) & (K Units) Table 160. China IL-17 Targeting Biological Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 161. China IL-17 Targeting Biological Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 162. Asia IL-17 Targeting Biological Drugs Revenue by Type (2021-2026) & (US$ Million) Table 163. Asia IL-17 Targeting Biological Drugs Revenue by Type (2027-2032) & (US$ Million) Table 164. Asia IL-17 Targeting Biological Drugs Sales by Type (2021-2026) & (K Units) Table 165. Asia IL-17 Targeting Biological Drugs Sales by Type (2027-2032) & (K Units) Table 166. Asia IL-17 Targeting Biological Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 167. Asia IL-17 Targeting Biological Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 168. Asia IL-17 Targeting Biological Drugs Revenue by Application (2021-2026) & (US$ Million) Table 169. Asia IL-17 Targeting Biological Drugs Revenue by Application (2027-2032) & (US$ Million) Table 170. Asia IL-17 Targeting Biological Drugs Sales by Application (2021-2026) & (K Units) Table 171. Asia IL-17 Targeting Biological Drugs Sales by Application (2027-2032) & (K Units) Table 172. Asia IL-17 Targeting Biological Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 173. Asia IL-17 Targeting Biological Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 174. Asia IL-17 Targeting Biological Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 175. Asia IL-17 Targeting Biological Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 176. Asia IL-17 Targeting Biological Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 177. Asia IL-17 Targeting Biological Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 178. Asia IL-17 Targeting Biological Drugs Sales by Country (2021-2026) & (K Units) Table 179. Asia IL-17 Targeting Biological Drugs Sales by Country (2027-2032) & (K Units) Table 180. Asia IL-17 Targeting Biological Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 181. Asia IL-17 Targeting Biological Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 182. Japan IL-17 Targeting Biological Drugs Revenue (2021-2032) & (US$ Million) Table 183. South Korea IL-17 Targeting Biological Drugs Revenue (2021-2032) & (US$ Million) Table 184. India IL-17 Targeting Biological Drugs Revenue (2021-2032) & (US$ Million) Table 185. Australia IL-17 Targeting Biological Drugs Revenue (2021-2032) & (US$ Million) Table 186. Taiwan IL-17 Targeting Biological Drugs Revenue (2021-2032) & (US$ Million) Table 187. Southeast Asia IL-17 Targeting Biological Drugs Revenue (2021-2032) & (US$ Million) Table 188. SAMEA IL-17 Targeting Biological Drugs Revenue by Type (2021-2026) & (US$ Million) Table 189. SAMEA IL-17 Targeting Biological Drugs Revenue by Type (2027-2032) & (US$ Million) Table 190. SAMEA IL-17 Targeting Biological Drugs Sales by Type (2021-2026) & (K Units) Table 191. SAMEA IL-17 Targeting Biological Drugs Sales by Type (2027-2032) & (K Units) Table 192. SAMEA IL-17 Targeting Biological Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 193. SAMEA IL-17 Targeting Biological Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 194. SAMEA IL-17 Targeting Biological Drugs Revenue by Application (2021-2026) & (US$ Million) Table 195. SAMEA IL-17 Targeting Biological Drugs Revenue by Application (2027-2032) & (US$ Million) Table 196. SAMEA IL-17 Targeting Biological Drugs Sales by Application (2021-2026) & (K Units) Table 197. SAMEA IL-17 Targeting Biological Drugs Sales by Application (2027-2032) & (K Units) Table 198. SAMEA IL-17 Targeting Biological Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 199. SAMEA IL-17 Targeting Biological Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 200. SAMEA IL-17 Targeting Biological Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 201. SAMEA IL-17 Targeting Biological Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 202. SAMEA IL-17 Targeting Biological Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 203. SAMEA IL-17 Targeting Biological Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 204. SAMEA IL-17 Targeting Biological Drugs Sales by Country (2021-2026) & (K Units) Table 205. SAMEA IL-17 Targeting Biological Drugs Sales by Country (2027-2032) & (K Units) Table 206. SAMEA IL-17 Targeting Biological Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 207. SAMEA IL-17 Targeting Biological Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 208. Brazil IL-17 Targeting Biological Drugs Revenue (2021-2032) & (US$ Million) Table 209. Argentina IL-17 Targeting Biological Drugs Revenue (2021-2032) & (US$ Million) Table 210. Chile IL-17 Targeting Biological Drugs Revenue (2021-2032) & (US$ Million) Table 211. Colombia IL-17 Targeting Biological Drugs Revenue (2021-2032) & (US$ Million) Table 212. Peru IL-17 Targeting Biological Drugs Revenue (2021-2032) & (US$ Million) Table 213. Saudi Arabia IL-17 Targeting Biological Drugs Revenue (2021-2032) & (US$ Million) Table 214. Israel IL-17 Targeting Biological Drugs Revenue (2021-2032) & (US$ Million) Table 215. UAE IL-17 Targeting Biological Drugs Revenue (2021-2032) & (US$ Million) Table 216. Turkey IL-17 Targeting Biological Drugs Revenue (2021-2032) & (US$ Million) Table 217. Iran IL-17 Targeting Biological Drugs Revenue (2021-2032) & (US$ Million) Table 218. Egypt IL-17 Targeting Biological Drugs Revenue (2021-2032) & (US$ Million) Table 219. Key Raw Materials Table 220. Raw Materials Key Suppliers Table 221. IL-17 Targeting Biological Drugs Distributors List Table 222. IL-17 Targeting Biological Drugs Customers List Table 223. Research Programs/Design for This Report Table 224. Authors List of This Report Table 225. Secondary Sources Table 226. Primary Sources List of Figures Figure 1. IL-17 Targeting Biological Drugs Image Figure 2. Global IL-17 Targeting Biological Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global IL-17 Targeting Biological Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 4. Oral Image Figure 5. Injection Image Figure 6. Global IL-17 Targeting Biological Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global IL-17 Targeting Biological Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Clinic Image Figure 10. Other Image Figure 11. Global IL-17 Targeting Biological Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global IL-17 Targeting Biological Drugs Revenue (2021-2032) & (US$ Million) Figure 13. Global IL-17 Targeting Biological Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global IL-17 Targeting Biological Drugs Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global IL-17 Targeting Biological Drugs Revenue Market Share by Region (2021-2032) Figure 16. Global IL-17 Targeting Biological Drugs Sales (2021-2032) & (K Units) Figure 17. Global IL-17 Targeting Biological Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 18. Global IL-17 Targeting Biological Drugs Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico IL-17 Targeting Biological Drugs Sales YoY (2021-2032) & (K Units) Figure 20. Europe IL-17 Targeting Biological Drugs Sales YoY (2021-2032) & (K Units) Figure 21. China IL-17 Targeting Biological Drugs Sales YoY (2021-2032) & (K Units) Figure 22. Asia (Excluding China) IL-17 Targeting Biological Drugs Sales YoY (2021-2032) & (K Units) Figure 23. South America, Middle East and Africa IL-17 Targeting Biological Drugs Sales YoY (2021-2032) & (K Units) Figure 24. Global IL-17 Targeting Biological Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global IL-17 Targeting Biological Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global IL-17 Targeting Biological Drugs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global IL-17 Targeting Biological Drugs Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global IL-17 Targeting Biological Drugs Revenue Market Share by Type (2021-2032) Figure 30. Global IL-17 Targeting Biological Drugs Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 31. Global IL-17 Targeting Biological Drugs Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global IL-17 Targeting Biological Drugs Sales Market Share by Type (2021-2032) Figure 33. Global IL-17 Targeting Biological Drugs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global IL-17 Targeting Biological Drugs Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global IL-17 Targeting Biological Drugs Revenue Market Share by Application (2021-2032) Figure 36. Global IL-17 Targeting Biological Drugs Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 37. Global IL-17 Targeting Biological Drugs Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global IL-17 Targeting Biological Drugs Sales Market Share by Application (2021-2032) Figure 39. North America IL-17 Targeting Biological Drugs Revenue Share by Type (2021-2032) Figure 40. North America IL-17 Targeting Biological Drugs Sales Share by Type (2021-2032) Figure 41. North America IL-17 Targeting Biological Drugs Revenue Share by Application (2021-2032) Figure 42. North America IL-17 Targeting Biological Drugs Sales Share by Application (2021-2032) Figure 43. North America IL-17 Targeting Biological Drugs Revenue Share by Country (2021-2032) Figure 44. North America IL-17 Targeting Biological Drugs Sales Share by Country (2021-2032) Figure 45. Europe IL-17 Targeting Biological Drugs Revenue Share by Type (2021-2032) Figure 46. Europe IL-17 Targeting Biological Drugs Sales Share by Type (2021-2032) Figure 47. Europe IL-17 Targeting Biological Drugs Revenue Share by Application (2021-2032) Figure 48. Europe IL-17 Targeting Biological Drugs Sales Share by Application (2021-2032) Figure 49. Europe IL-17 Targeting Biological Drugs Revenue Share by Country (2021-2032) Figure 50. Europe IL-17 Targeting Biological Drugs Sales Share by Country (2021-2032) Figure 51. China IL-17 Targeting Biological Drugs Revenue Share by Type (2021-2032) Figure 52. China IL-17 Targeting Biological Drugs Sales Share by Type (2021-2032) Figure 53. China IL-17 Targeting Biological Drugs Revenue Share by Application (2021-2032) Figure 54. China IL-17 Targeting Biological Drugs Sales Share by Application (2021-2032) Figure 55. Asia IL-17 Targeting Biological Drugs Revenue Share by Type (2021-2032) Figure 56. Asia IL-17 Targeting Biological Drugs Sales Share by Type (2021-2032) Figure 57. Asia IL-17 Targeting Biological Drugs Revenue Share by Application (2021-2032) Figure 58. Asia IL-17 Targeting Biological Drugs Sales Share by Application (2021-2032) Figure 59. Asia IL-17 Targeting Biological Drugs Revenue Share by Country (2021-2032) Figure 60. Asia IL-17 Targeting Biological Drugs Sales Share by Country (2021-2032) Figure 61. SAMEA IL-17 Targeting Biological Drugs Revenue Share by Type (2021-2032) Figure 62. SAMEA IL-17 Targeting Biological Drugs Sales Share by Type (2021-2032) Figure 63. SAMEA IL-17 Targeting Biological Drugs Revenue Share by Application (2021-2032) Figure 64. SAMEA IL-17 Targeting Biological Drugs Sales Share by Application (2021-2032) Figure 65. SAMEA IL-17 Targeting Biological Drugs Revenue Share by Country (2021-2032) Figure 66. SAMEA IL-17 Targeting Biological Drugs Sales Share by Country (2021-2032) Figure 67. IL-17 Targeting Biological Drugs Value Chain Figure 68. Manufacturing Cost Structure Figure 69. IL-17 Targeting Biological Drugs Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Oral
  • Injection
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • AstraZeneca
  • DICE Therapeutics
  • Eli Lilly and Co.
  • Novartis
  • UCB
  • Jiangsu Hengrui Medicine
  • Akesobio
  • Chongqing Genrix Biopharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 IL-17 Targeting Biological Drugs Market by Type
  3. 1.2.1 Global IL-17 Targeting Biological Drugs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Oral
  5. 1.2.3 Injection
  6. 1.3 IL-17 Targeting Biological Drugs Market by Application
  7. 1.3.1 Global IL-17 Targeting Biological Drugs Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Clinic
  10. 1.3.4 Other
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 IL-17 Targeting Biological Drugs Market Dynamics
  1. 2.1 IL-17 Targeting Biological Drugs Industry Trends
  2. 2.2 IL-17 Targeting Biological Drugs Industry Drivers
  3. 2.3 IL-17 Targeting Biological Drugs Industry Opportunities and Challenges
  4. 2.4 IL-17 Targeting Biological Drugs Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global IL-17 Targeting Biological Drugs Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global IL-17 Targeting Biological Drugs Revenue by Region
  3. 3.2.1 Global IL-17 Targeting Biological Drugs Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global IL-17 Targeting Biological Drugs Revenue by Region (2021-2026)
  5. 3.2.3 Global IL-17 Targeting Biological Drugs Revenue by Region (2027-2032)
  6. 3.2.4 Global IL-17 Targeting Biological Drugs Revenue Market Share by Region (2021-2032)
  7. 3.3 Global IL-17 Targeting Biological Drugs Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global IL-17 Targeting Biological Drugs Sales by Region
  9. 3.4.1 Global IL-17 Targeting Biological Drugs Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global IL-17 Targeting Biological Drugs Sales by Region (2021-2026)
  11. 3.4.3 Global IL-17 Targeting Biological Drugs Sales by Region (2027-2032)
  12. 3.4.4 Global IL-17 Targeting Biological Drugs Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global IL-17 Targeting Biological Drugs Revenue by Manufacturers
  2. 4.1.1 Global IL-17 Targeting Biological Drugs Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global IL-17 Targeting Biological Drugs Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global IL-17 Targeting Biological Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global IL-17 Targeting Biological Drugs Sales by Manufacturers
  6. 4.2.1 Global IL-17 Targeting Biological Drugs Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global IL-17 Targeting Biological Drugs Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global IL-17 Targeting Biological Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global IL-17 Targeting Biological Drugs Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global IL-17 Targeting Biological Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global IL-17 Targeting Biological Drugs Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global IL-17 Targeting Biological Drugs Manufacturers, Product Type & Application
  13. 4.7 Global IL-17 Targeting Biological Drugs Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global IL-17 Targeting Biological Drugs Market CR5 and HHI
  16. 4.8.2 2025 IL-17 Targeting Biological Drugs Tier 1, Tier 2, and Tier 3
5 IL-17 Targeting Biological Drugs Market by Type
  1. 5.1 Global IL-17 Targeting Biological Drugs Revenue by Type
  2. 5.1.1 Global IL-17 Targeting Biological Drugs Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global IL-17 Targeting Biological Drugs Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global IL-17 Targeting Biological Drugs Revenue Market Share by Type (2021-2032)
  5. 5.2 Global IL-17 Targeting Biological Drugs Sales by Type
  6. 5.2.1 Global IL-17 Targeting Biological Drugs Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global IL-17 Targeting Biological Drugs Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global IL-17 Targeting Biological Drugs Sales Market Share by Type (2021-2032)
  9. 5.3 Global IL-17 Targeting Biological Drugs Price by Type
6 IL-17 Targeting Biological Drugs Market by Application
  1. 6.1 Global IL-17 Targeting Biological Drugs Revenue by Application
  2. 6.1.1 Global IL-17 Targeting Biological Drugs Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global IL-17 Targeting Biological Drugs Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global IL-17 Targeting Biological Drugs Revenue Market Share by Application (2021-2032)
  5. 6.2 Global IL-17 Targeting Biological Drugs Sales by Application
  6. 6.2.1 Global IL-17 Targeting Biological Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global IL-17 Targeting Biological Drugs Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global IL-17 Targeting Biological Drugs Sales Market Share by Application (2021-2032)
  9. 6.3 Global IL-17 Targeting Biological Drugs Price by Application
7 Company Profiles
  1. 7.1 AstraZeneca
  2. 7.1.1 AstraZeneca Company Information
  3. 7.1.2 AstraZeneca Business Overview
  4. 7.1.3 AstraZeneca IL-17 Targeting Biological Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 AstraZeneca IL-17 Targeting Biological Drugs Product Portfolio
  6. 7.1.5 AstraZeneca Recent Developments
  7. 7.2 DICE Therapeutics
  8. 7.2.1 DICE Therapeutics Company Information
  9. 7.2.2 DICE Therapeutics Business Overview
  10. 7.2.3 DICE Therapeutics IL-17 Targeting Biological Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 DICE Therapeutics IL-17 Targeting Biological Drugs Product Portfolio
  12. 7.2.5 DICE Therapeutics Recent Developments
  13. 7.3 Eli Lilly and Co.
  14. 7.3.1 Eli Lilly and Co. Company Information
  15. 7.3.2 Eli Lilly and Co. Business Overview
  16. 7.3.3 Eli Lilly and Co. IL-17 Targeting Biological Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Eli Lilly and Co. IL-17 Targeting Biological Drugs Product Portfolio
  18. 7.3.5 Eli Lilly and Co. Recent Developments
  19. 7.4 Novartis
  20. 7.4.1 Novartis Company Information
  21. 7.4.2 Novartis Business Overview
  22. 7.4.3 Novartis IL-17 Targeting Biological Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Novartis IL-17 Targeting Biological Drugs Product Portfolio
  24. 7.4.5 Novartis Recent Developments
  25. 7.5 UCB
  26. 7.5.1 UCB Company Information
  27. 7.5.2 UCB Business Overview
  28. 7.5.3 UCB IL-17 Targeting Biological Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 UCB IL-17 Targeting Biological Drugs Product Portfolio
  30. 7.5.5 UCB Recent Developments
  31. 7.6 Jiangsu Hengrui Medicine
  32. 7.6.1 Jiangsu Hengrui Medicine Company Information
  33. 7.6.2 Jiangsu Hengrui Medicine Business Overview
  34. 7.6.3 Jiangsu Hengrui Medicine IL-17 Targeting Biological Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Jiangsu Hengrui Medicine IL-17 Targeting Biological Drugs Product Portfolio
  36. 7.6.5 Jiangsu Hengrui Medicine Recent Developments
  37. 7.7 Akesobio
  38. 7.7.1 Akesobio Company Information
  39. 7.7.2 Akesobio Business Overview
  40. 7.7.3 Akesobio IL-17 Targeting Biological Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Akesobio IL-17 Targeting Biological Drugs Product Portfolio
  42. 7.7.5 Akesobio Recent Developments
  43. 7.8 Chongqing Genrix Biopharmaceutical
  44. 7.8.1 Chongqing Genrix Biopharmaceutical Company Information
  45. 7.8.2 Chongqing Genrix Biopharmaceutical Business Overview
  46. 7.8.3 Chongqing Genrix Biopharmaceutical IL-17 Targeting Biological Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Chongqing Genrix Biopharmaceutical IL-17 Targeting Biological Drugs Product Portfolio
  48. 7.8.5 Chongqing Genrix Biopharmaceutical Recent Developments
8 North America
  1. 8.1 North America IL-17 Targeting Biological Drugs Market Size by Type
  2. 8.1.1 North America IL-17 Targeting Biological Drugs Revenue by Type (2021-2032)
  3. 8.1.2 North America IL-17 Targeting Biological Drugs Sales by Type (2021-2032)
  4. 8.1.3 North America IL-17 Targeting Biological Drugs Price by Type (2021-2032)
  5. 8.2 North America IL-17 Targeting Biological Drugs Market Size by Application
  6. 8.2.1 North America IL-17 Targeting Biological Drugs Revenue by Application (2021-2032)
  7. 8.2.2 North America IL-17 Targeting Biological Drugs Sales by Application (2021-2032)
  8. 8.2.3 North America IL-17 Targeting Biological Drugs Price by Application (2021-2032)
  9. 8.3 North America IL-17 Targeting Biological Drugs Market Size by Country
  10. 8.3.1 North America IL-17 Targeting Biological Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America IL-17 Targeting Biological Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America IL-17 Targeting Biological Drugs Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe IL-17 Targeting Biological Drugs Market Size by Type
  2. 9.1.1 Europe IL-17 Targeting Biological Drugs Revenue by Type (2021-2032)
  3. 9.1.2 Europe IL-17 Targeting Biological Drugs Sales by Type (2021-2032)
  4. 9.1.3 Europe IL-17 Targeting Biological Drugs Price by Type (2021-2032)
  5. 9.2 Europe IL-17 Targeting Biological Drugs Market Size by Application
  6. 9.2.1 Europe IL-17 Targeting Biological Drugs Revenue by Application (2021-2032)
  7. 9.2.2 Europe IL-17 Targeting Biological Drugs Sales by Application (2021-2032)
  8. 9.2.3 Europe IL-17 Targeting Biological Drugs Price by Application (2021-2032)
  9. 9.3 Europe IL-17 Targeting Biological Drugs Market Size by Country
  10. 9.3.1 Europe IL-17 Targeting Biological Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe IL-17 Targeting Biological Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe IL-17 Targeting Biological Drugs Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China IL-17 Targeting Biological Drugs Market Size by Type
  2. 10.1.1 China IL-17 Targeting Biological Drugs Revenue by Type (2021-2032)
  3. 10.1.2 China IL-17 Targeting Biological Drugs Sales by Type (2021-2032)
  4. 10.1.3 China IL-17 Targeting Biological Drugs Price by Type (2021-2032)
  5. 10.2 China IL-17 Targeting Biological Drugs Market Size by Application
  6. 10.2.1 China IL-17 Targeting Biological Drugs Revenue by Application (2021-2032)
  7. 10.2.2 China IL-17 Targeting Biological Drugs Sales by Application (2021-2032)
  8. 10.2.3 China IL-17 Targeting Biological Drugs Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia IL-17 Targeting Biological Drugs Market Size by Type
  2. 11.1.1 Asia IL-17 Targeting Biological Drugs Revenue by Type (2021-2032)
  3. 11.1.2 Asia IL-17 Targeting Biological Drugs Sales by Type (2021-2032)
  4. 11.1.3 Asia IL-17 Targeting Biological Drugs Price by Type (2021-2032)
  5. 11.2 Asia IL-17 Targeting Biological Drugs Market Size by Application
  6. 11.2.1 Asia IL-17 Targeting Biological Drugs Revenue by Application (2021-2032)
  7. 11.2.2 Asia IL-17 Targeting Biological Drugs Sales by Application (2021-2032)
  8. 11.2.3 Asia IL-17 Targeting Biological Drugs Price by Application (2021-2032)
  9. 11.3 Asia IL-17 Targeting Biological Drugs Market Size by Country
  10. 11.3.1 Asia IL-17 Targeting Biological Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia IL-17 Targeting Biological Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia IL-17 Targeting Biological Drugs Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA IL-17 Targeting Biological Drugs Market Size by Type
  2. 12.1.1 SAMEA IL-17 Targeting Biological Drugs Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA IL-17 Targeting Biological Drugs Sales by Type (2021-2032)
  4. 12.1.3 SAMEA IL-17 Targeting Biological Drugs Price by Type (2021-2032)
  5. 12.2 SAMEA IL-17 Targeting Biological Drugs Market Size by Application
  6. 12.2.1 SAMEA IL-17 Targeting Biological Drugs Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA IL-17 Targeting Biological Drugs Sales by Application (2021-2032)
  8. 12.2.3 SAMEA IL-17 Targeting Biological Drugs Price by Application (2021-2032)
  9. 12.3 SAMEA IL-17 Targeting Biological Drugs Market Size by Country
  10. 12.3.1 SAMEA IL-17 Targeting Biological Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA IL-17 Targeting Biological Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA IL-17 Targeting Biological Drugs Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 IL-17 Targeting Biological Drugs Value Chain Analysis
  2. 13.1.1 IL-17 Targeting Biological Drugs Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 IL-17 Targeting Biological Drugs Production Mode & Process
  6. 13.2 IL-17 Targeting Biological Drugs Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 IL-17 Targeting Biological Drugs Distributors
  9. 13.2.3 IL-17 Targeting Biological Drugs Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst